Already have an account? Sign-in to get started.

Understanding Recent Progress in Pancreatic Cancer: Clinical Implications and Perspectives

Overview

This CME activity is available online at:  http://www.i3health.com/index.php/activities/pancreatic-cancer

To complete the required pre test, post test and evaluation and receive CME credit, please go to the website above.

Overview:  Pancreatic cancer is the fourth leading cause of cancer-related death in the United States. An estimated 48,960 new cases are diagnosed annually, and 40,560 people die of the disease. Most patients present with locally advanced or metastatic disease, and only 28% survive longer than 1 year. During the past decade, pancreatic cancer death rates have been slowly increasing among US men and women, in contrast to the downward trend in rates for most other major cancer sites, such as lung, colorectum, female breast, and prostate. The lack of progress in primary prevention, early diagnosis, and treatment of pancreatic cancer represents a significant unmet medical need.

Target Audience:  Oncology physicians, advanced practitioners, and other health care professionals involved in the treatment of pancreatic cancer.

Objectives

Upon completion of this activtiy, participants should be able to: 

  • Evaluate treatment selection considerations for patients with locally advanced pancreatic cancer.
  • Assess recent clinical trial findings on conventional and novel therapies for metastatic pancreatic cancer.
  • Manage the side effects of conventional and novel therapies for pancreatic cancer.

Statements

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Cincinnati and I3 Health Education. The University of Cincinnati is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Cincinnati designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Your Status

STEP
1

Comments

People have also taken...

Rating